Spring direct naar de hoofdnavigatie of de inhoud
‘IP belongs to a company’s most powerful assets, profitable in all economic conditions.’
Raimondo Cau

Raimondo Cau

  • Hightech & Electronics
  • European and Dutch Patent Attorney
  • Associate

Before starting his career as a patent attorney, Raimondo Cau was inventor and co-founder of a medical robotics startup in which he was active as CTO until it had reached a mature stage.

Continue reading

He led the company’s R&D and IP program and was involved in several fundraising activities. He is used to keeping an overview in complex matters and dealing with various stakeholders across disciplines and levels. Raimondo has a background in Mechanical Engineering (PhD), a system-thinking attitude and is specialized in robotics, (opto)mechatronics, precision engineering and medical devices.

Working experience

  •  Patent attorney, V.O. (June 2023)
  •  CTO and cofounder, Microsure (2016 – 2020)
  • IEC/ISO technical standard committee member (2017 – 2019)
  • Project leader, Medical Robotic Technologies (2014 – 2016)
  • Mechanical designer, MAN Turbo (2008 – 2009)

Education

  • ISO 14791 Risk Management for Medical Devices (2016)
  • PhD in Mechanical Engineering, Control Systems Technology, Medical Robotics, Eindhoven University of Technology (2014)
  • MSc in Mechanical Engineering, Control Systems Technology, Precision Engineering, Eindhoven University of Technology (2009)
  • International Baccalaureate English Level A2 (near native), Cambridge Undergraduate Study (2002)

Publications

  • Cau R. Robotic Manipulator Interface for Hinged Surgical Tools. EP3363401 (A1)
  • Cau R. Surgical Robotic System with Carriage and Manipulator Unit. EP3366255 (A1)
  • Cau R. Microsurgical Robot System. EP2731535 (B1), US9351796 (B2)
  • Van Mulken TJM, Schols RM, Scharmga AMJ, Winkens B, Cau R, Schoenmakers FBF, Qiu SS, van der Hulst RRWJ. First-in-human robotic supermicrosurgery using a dedicated microsurgical robot for treating breast cancer-related lymphedema: a randomized pilot trial. Nat Commun. 2020;11(1):757
  • Van Mulken TJM, Scharmga AMJ, Schols RM, Cau R, Jonis Y, Qiu SS, van der Hulst RRWJ. The journey of creating the first dedicated platform for robot-assisted (super)microsurgery in reconstructive surgery. Eur J Plast Surg. 2020;43:1-6
  • Van Mulken TJM, Boymans CAEM, Schols RM, Cau R, Schoenmakers FBF, Hoekstra LT, Qiu SS, Selber JC, van der Hulst RRWJ. Preclinical experience using a new robotic system created for microsurgery. Plast Reconstr Surg. 2018;142(5):1367-1376
  • Van Mulken TJM, Schols RM, Qiu SS, Brouwers K, Hoekstra LT, Booi DI, Cau R, Schoenmakers F, Scharmga AMJ, van der Hulst RRWJ. Robotic (super) microsurgery: Feasibility of a new master-slave platform in an in vivo animal model and future directions. J Surg Oncol. 2018;118(5):826-831
  • Cau R, Schoenmakers FBF, Steinbuch M, van Mulken TJM, van der Hulst RRWJ. Design and preliminary test results of a novel microsurgical telemanipulator system. 5th IEEE RAS/EMBS International Conference on Biomedical Robotics and Biomechatronics, Sao Paulo, 2014, pp. 352-356
  • Cau R. Design and realization of a master-slave system for reconstructive microsurgery. Eindhoven: Eindhoven University of Technology; 2014

Languages

  • English
  • Dutch
  • German

 

Also see these experts

Jasper Groot Koerkamp

Jasper Groot Koerkamp

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
Marlon Blood

Marlon Blood

  • European Patent Attorney
  • Senior Associate
More experts

News

UPC anti-anti-suit injunctions as interim measures: Munich Local Division in Huawei v Netgear (UPC_CFI_791/2024)

In its Order of 11 December 2024 in UPC_CFI_791/2024 (Munich Local Division), the Unified Patent Court (UPC) granted an ex parte anti-anti-suit/anti-enforcement injunction (AASI/AAEI) to prevent steps in US proceedings that were said to obstruct UPC patent enforcement. The decision is noteworthy for its articulation of the UPC’s jurisdictional basis and the procedural framework for […]Continue reading

R 0016/23: the Enlarged Board confirms the mandatory nature of oral proceedings upon request under Article 116(1) EPC 

In R 0016/23 (Enlarged Board of Appeal, 21 November 2025), the Enlarged Board set aside a Legal Board of Appeal decision which had dismissed an appeal without holding requested oral proceedings. The decision is a clear statement that efficiency and “timely legal certainty” cannot, in themselves, justify restricting the scope of Article 116(1) EPC when […]Continue reading

Medical-device infringement and “standard use”: LD Munich on lege artis use and conditional revocation counterclaims (UPC_CFI_628/2024) 

In its decision on the merits in UPC_CFI_628/2024 (with the related revocation counterclaim UPC_CFI_125/2025), the Munich Local Division of the Unified Patent Court (UPC) addressed two practically relevant issues:Continue reading